Blog

Gerard: ‘We both knew that what we were about to do could change the world’

Tessa Aminetzah
Blog

The latest developments in fluorescence imaging

Pieter Steinkamp, MD, PhD cand.
Blog

Radiopharmaceuticals are on the rise as drug developers realize enormous potential

Prof. G.M. van Dam, MD, PhD
Blog

How to determine clinical endpoints for fluorescence-guided surgery

Prof. G.M. van Dam, MD, PhD
Blog

How does cardiovascular imaging work?

Prof. G.M. van Dam, MD, PhD
Blog

How to generate in-human data on antibodies with microdosing

Pieter Steinkamp, MD, PhD cand.
Blog

Hitting the R&D sweet spot with fast in-human studies

Prof. G.M. van Dam, MD, PhD
Blog

5 must read articles that changed the molecular imaging space

Prof. G.M. van Dam, MD, PhD
Blog

What are clinical molecular imaging studies?

Pieter Steinkamp, MD, PhD cand.
Blog

The use of nuclear and optical molecular imaging in drug development

Prof. G.M. van Dam, MD, PhD
Blog

How to use in-human data as an investment strategy

Ari Aminetzah, MBA, PhD cand.
Blog

How to transform your compound into in-human data in five steps

Prof. G.M. van Dam, MD, PhD
Blog

How to achieve a broad implementation of molecular imaging in drug development

Maarten Brom, PhD
Blog

How molecular imaging helps predict immunotherapy response

Maarten Brom, PhD
Blog

In-Human Microdosing

Prof G.M. Van Dam, MD, PhD